Literature DB >> 2921451

Familial aggregation of multiple myeloma and central nervous system diseases.

S Grufferman1, H J Cohen, E S Delzell, M C Morrison, S C Schold, J O Moore.   

Abstract

Degenerative central nervous system diseases such as Alzheimer's disease and lymphoreticular malignancies such as multiple myeloma occur with increased frequency with advancing age. Relatives of early-onset Alzheimer's disease patients may have an increased risk of lymphoreticular malignancies. This led us to evaluate the family history of central nervous system diseases in a case-control study of multiple myeloma. Thirteen of 439 multiple myeloma cases had one or more first-degree relatives with degenerative or demyelinating central nervous system disease. In comparison, there were nine "positive" family histories in 1,317 matched hospital controls (relative risk = 4.4, 95% confidence interval = 1.9-10.3). Relative risks for the component categories of Parkinson's disease, multiple sclerosis, and miscellaneous degenerative central nervous system diseases were 3.0, 4.0 and 11.9, respectively. Our findings suggest that the degenerative and demyelinating central nervous system diseases and the lymphoreticular malignancies may comprise an etiologically related group of "protean diseases." These diseases may have a shared genetic susceptibility, possibly an immunologic abnormality. The varied disease manifestation in family members suggests a second necessary etiologic step of a variable and possibly environmental nature.

Entities:  

Mesh:

Year:  1989        PMID: 2921451     DOI: 10.1111/j.1532-5415.1989.tb05495.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  3 in total

1.  A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry.

Authors:  Zhaohui Du; Niels Weinhold; Gregory Chi Song; Kristin A Rand; David J Van Den Berg; Amie E Hwang; Xin Sheng; Victor Hom; Sikander Ailawadhi; Ajay K Nooka; Seema Singhal; Karen Pawlish; Edward S Peters; Cathryn Bock; Ann Mohrbacher; Alexander Stram; Sonja I Berndt; William J Blot; Graham Casey; Victoria L Stevens; Rick Kittles; Phyllis J Goodman; W Ryan Diver; Anselm Hennis; Barbara Nemesure; Eric A Klein; Benjamin A Rybicki; Janet L Stanford; John S Witte; Lisa Signorello; Esther M John; Leslie Bernstein; Antoinette M Stroup; Owen W Stephens; Maurizio Zangari; Frits Van Rhee; Andrew Olshan; Wei Zheng; Jennifer J Hu; Regina Ziegler; Sarah J Nyante; Sue Ann Ingles; Michael F Press; John David Carpten; Stephen J Chanock; Jayesh Mehta; Graham A Colditz; Jeffrey Wolf; Thomas G Martin; Michael Tomasson; Mark A Fiala; Howard Terebelo; Nalini Janakiraman; Laurence Kolonel; Kenneth C Anderson; Loic Le Marchand; Daniel Auclair; Brian C-H Chiu; Elad Ziv; Daniel Stram; Ravi Vij; Leon Bernal-Mizrachi; Gareth J Morgan; Jeffrey A Zonder; Carol Ann Huff; Sagar Lonial; Robert Z Orlowski; David V Conti; Christopher A Haiman; Wendy Cozen
Journal:  Blood Adv       Date:  2020-01-14

2.  Familial occurrence of hematologic malignancies and other diseases in multiple myeloma: a case-control study.

Authors:  M Eriksson; B Hållberg
Journal:  Cancer Causes Control       Date:  1992-01       Impact factor: 2.506

Review 3.  Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Alexei Shimanovsky; Juliana Alvarez Argote; Shruti Murali; Constantin A Dasanu
Journal:  BBA Clin       Date:  2016-05-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.